Explore the latest in vaccination, including recent advances in child and adult immunization and studies of vaccine refusal and safety.
This Viewpoint analyzes the justification and legal issues for mandatory annual influenza vaccination among infants and children aged 6 months to 59 months in childcare and educational institutions in New York City.
This Medical Letter review summarizes information on the timing, composition, effectiveness, and adverse effects of the 2018-2019 influenza vaccine.
This systematic review and meta-analysis examines the safety and efficacy of bacillus Calmette-Guérin vaccination at birth or later points in infants who are preterm and/or had low birth weights compared with ones who are full term and/or had normal birth weights.
This Medical News article examines the ongoing debate about whether people should begin getting immunized against influenza as soon as the vaccine becomes available.
This Viewpoint discusses strategies for debunking health misinformation on social media and ideas for ways to spread accurate health information.
This Viewpoint promotes implementing state-level school entry requirements for the human papillomavirus vaccine for US adolescents.
This randomized clinical trial compares IgG antibody responses to vaccine antigens at age 6, 10, 24, and 32 weeks between newborn infants receiving the monovalent acellular pertussis vaccine and the hepatitis B vaccine and those receiving the hepatitis B vaccine alone.
This case-control study assesses the association of prior-season influenza vaccination with vaccine effectiveness by different vaccine types and influenza types and subtypes among US children aged 2 to 17 years.
This prospective cohort study assesses whether maternal immunization with tetanus, diphtheria, and acellular pertussis (Tdap) vaccine, compared with no immunization, is associated with high concentrations of pertussis toxin antibodies at birth and if there is an optimal gestational age for maternal immunization.
This analysis of data from the Global Burden of Disease Study examines the extent of rotavirus infection and associated deaths among children younger than 5 years worldwide and whether the rotavirus vaccine has reduced the diarrhea-associated mortality.
This phase 2 clinical trial examines whether the efficacy of nivolumab is amplified through treatment with ISA 101, a synthetic long-peptide human papillomavirus 16 vaccine, in patients with incurable human papillomavirus 16–positive cancer.
This quality improvement study compares differences in influenza vaccination rates by clinic appointment time and evaluates whether an active choice intervention in the electronic health record is associated with changes in vaccination rates.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: